Sanctions Fuel Innovation Huaweis Hers Law Challenge in the Global Tech Race TOL Q1 2026 Earnings EPS Surprises to the Upside Stock Edges Higher Novartis Lifts FullYear Sales and Profit Outlook on Strong Drug Portfolio